How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | SOLVSolventum Corp | 950130.KQ950130.KQ | MDLNMedline Inc. | COOCOOPER COMPANIES, INC. | Median of the restexcluding SOLV |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $86.67▲ 0.28 (0.32%) | ₩1959.00▼ 46.00 (2.29%) | $35.31▼ 0.15 (0.42%) | $61.65▲ 2.68 (4.54%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 4.7/10 | 2.0/10 | 6.0/10 | 7.0/10 | 6.0/10 |
| Market value | $15.04B | $68.91B | $28.60B | $12.08B | |
| Revenue | $8.32B | $31.26B | $28.43B | $4.09B | |
| Profit | $1.56B | -$82.12B | $1.16B | $374.9M | |
| Revenue growthChange in sales versus the prior year. | 0.9% | -72.2% | 11.5% | 5.1% | 5.1% |
| Gross marginShare of sales left after the direct cost of producing them. | 53.5% | -78.2% | 26.4% | 65.5% | 26.4% |
| Operating marginShare of sales left after running the business, before interest and tax. | 26.2% | -202.5% | 7.8% | 16.7% | 7.8% |
| Profit marginProfit kept from each dollar of sales. | 18.7% | -262.7% | 4.1% | 9.2% | 4.1% |
| Free cash flow marginCash left after capital spending, as a share of sales. | -0.1% | -99.1% | 4.6% | 10.6% | 4.6% |
| Return on equityProfit against the owners' stake in the company. | 30.8% | -14.7% | 10.8% | 4.6% | 4.6% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 21.5% | -20.1% | 9.6% | 4.3% | 4.3% |
| P/E ratioPrice paid per dollar of annual profit. | 9.66x | — | 24.68x | 32.21x | 28.45x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 7.19x | — | 12.17x | 13.65x | 12.91x |
| Price to book | 2.98x | 0.12x | 2.66x | 1.47x | 1.47x |
| Debt to equityTotal liabilities compared with owners' stake. | 1.83x | 0.09x | 1.79x | 0.50x | 0.50x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 7/9 | 3/8 | 6/8 | 6/9 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | grey | safe | grey | safe |
How SOLV compares with the others
- SOLV's operating margin of 26.2% is higher than the median of the other companies selected (7.8%).
- Its revenue grew more slowly than the median of the other companies selected: 0.9% against 5.1%.
- It trades at a lower P/E than the median of the other companies selected: 9.7x against 28.4x.
- Its liabilities are higher relative to equity than the median of the other companies selected: 1.8x against 0.5x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.